Michael R. McDonnell

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Danbury, CT
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Brian G. Lloyd, Attorney-in-Fact
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Michael R. McDonnell

Form 4 holding EVP, Chief Financial Officer

BIOGEN INC.

Security class
Common Stock
Shares / value
24,341
Estimated value
$3,469,566
Report date
10 Feb 2025
Price
$142.54
Ownership
Direct
Form 4 holding EVP, Chief Financial Officer

BIOGEN INC.

Security class
Performance Stock Unit
Shares / value
0
Estimated value
$0
Report date
16 Feb 2024
Price
$219.08
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding EVP, Chief Financial Officer

BIOGEN INC.

Security class
Restricted Stock Unit
Shares / value
0
Estimated value
$0
Report date
10 Feb 2025
Price
$142.54
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding EVP, Chief Financial Officer

BIOGEN INC.

Security class
Restricted Stock Unit
Shares / value
0
Estimated value
$0
Report date
16 Feb 2024
Price
$219.08
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Michael R. McDonnell

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .